Print Page | Close Window

Corporate Profile

Gilead Sciences is a biopharmaceutical company that discovers, develops and commercializes innovative therapeutics in areas of unmet medical need. The company's mission is to advance the care of patients suffering from life-threatening diseases worldwide. Gilead has operations in more than 30 countries worldwide, with headquarters in Foster City, California.

Recent Press Releases

March 02, 2015 - 5:00 p.m.
Gilead Sciences to Present at the Cowen and Company 35th Annual Health Care Conference on Tuesday, March 3Printer Friendly Version 
February 26, 2015 - 7:06 p.m.
Gilead Announces Phase 3 Results for Investigational Once-Daily Single Tablet HIV Regimen Containing Tenofovir Alafenamide (TAF)Printer Friendly Version 

Upcoming Events

Tuesday, March 3, 2015 9:20 a.m. ET
Cowen & Company 35th Annual Health Care Conference
LocationBoston, MA
Wednesday, March 11, 2015 10:15 a.m. ET
Barclays Global Healthcare Conference
LocationMiami, FL
Thursday, March 12, 2015 through Sunday, March 15, 2015
24th Conference of the Asian Pacific Association for the Study of the Liver (APASL)
LocationIstanbul, Turkey
Saturday, March 14, 2015 through Monday, March 16, 2015
American College of Cardiology 2015: 64th Annual Scientific Session & Expo (ACC)
LocationSan Diego, CA
Wednesday, April 22, 2015 through Sunday, April 26, 2015
50th Annual Meeting of the European Association for the Study of the Liver (EASL): The International Liver Congress 2015
LocationVienna, Austria

Most Viewed Links

Updated 01/31/15
2.SEC Filings
3.Stock Information
4.Annual Reports
5.Fundamentals - Snapshot
* Data collected 01/23/15 - 01/30/15

Replication or redistribution of EDGAR Online, Inc. content is expressly prohibited without the prior written consent of EDGAR Online, Inc. EDGAR Online, Inc. shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon.